Cargando…
AXL is a candidate receptor for SARS-CoV-2 that promotes infection of pulmonary and bronchial epithelial cells
The current coronavirus disease 2019 (COVID-19) pandemic presents a global public health challenge. The viral pathogen responsible, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), binds to the host receptor ACE2 through its spike (S) glycoprotein, which mediates membrane fusion and vir...
Autores principales: | Wang, Shuai, Qiu, Zongyang, Hou, Yingnan, Deng, Xiya, Xu, Wei, Zheng, Tingting, Wu, Peihan, Xie, Shaofang, Bian, Weixiang, Zhang, Chong, Sun, Zewei, Liu, Kunpeng, Shan, Chao, Lin, Aifu, Jiang, Shibo, Xie, Youhua, Zhou, Qiang, Lu, Lu, Huang, Jing, Li, Xu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Singapore
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7791157/ https://www.ncbi.nlm.nih.gov/pubmed/33420426 http://dx.doi.org/10.1038/s41422-020-00460-y |
Ejemplares similares
-
lncRNA BREA2 promotes metastasis by disrupting the WWP2-mediated ubiquitination of Notch1
por: Zhang, Zhen, et al.
Publicado: (2023) -
A highly potent and stable pan-coronavirus fusion inhibitor as a candidate prophylactic and therapeutic for COVID-19 and other coronavirus diseases
por: Zhou, Jie, et al.
Publicado: (2022) -
RBD-Fc-based COVID-19 vaccine candidate induces highly potent SARS-CoV-2 neutralizing antibody response
por: Liu, Zezhong, et al.
Publicado: (2020) -
Giving AXL the axe: targeting AXL in human malignancy
por: Gay, Carl M, et al.
Publicado: (2017) -
Retraction Note to: SARS-CoV-2 infects T lymphocytes through its spike protein-mediated membrane fusion
por: Wang, Xinling, et al.
Publicado: (2020)